Keyword: Elan CVR

News

Elan Board Unanimously Rejects Royalty Pharma Bid

22.04.2013 - The board of Irish drugmaker Elan unanimously rejected a formal bid from Royalty Pharma on Monday, saying the U.S. investment firm's offer of $11.25 a share grossly undervalues the...

News

J&J Stake Sale Clouds Royalty Bid for Elan

19.04.2013 - U.S. healthcare firm Johnson & Johnson cut its stake in Elan on Thursday in a move that clouds prospects for a $7.3 billion takeover bid for the Irish drugmaker. U.S. investment...

News

Royalty Pharma Considers Sweetened Deal for Elan

12.04.2013 - U.S. investment firm Royalty Pharma is considering sweetening its $6.6 billion offer for Irish drugmaker Elan by paying Elan shareholders more if the multiple sclerosis drug...